IMV INC.

IMV
Delayed Quote. Delayed  - 01/15 04:00:00 pm
4.44CAD +1.83%

Turn to zoom
Prev.4.3600
Open4.5000
High4.5700
Low4.3900
Volume220 440
Latest news
01/04
12/29
12/29
12/28
Chart IMV INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBearishBullish
Resistance4,485,266,87
Spread/Res.-0,89%-16%-35%
Spread/Supp.19%19%15%
Support3,733,733,87
Financials
Sales 2020 0,27 M 0,21 M 0,21 M
Net income 2020 -33,3 M -26,2 M -26,2 M
Net Debt 2020 - - -
P/E ratio 2020 -8,20x
Yield 2020 -
Capitalization 298 M 234 M 234 M
Capi. / Sales 2020 1 103x
Capi. / Sales 2021 202x
Nbr of Employees 62
Free-Float 99,4%
Company
IMV Inc. is a clinical stage biopharmaceutical company focused on developing cancer immunotherapies and vaccines against infectious diseases, including coronavirus disease 2019 (COVID-19). The Company develops cancer-targeted immunotherapies and vaccines based on the Company’s platform, DPX. The...

>> Read more
Sector :
Biotechnology & Medical Research - NEC
Calendar :
2021-03-24 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 8,42 CAD
Last Close Price 4,44 CAD
Spread / Highest target 148%
Spread / Average Target 89,7%
Spread / Lowest Target -11,5%